Quote:
Originally Posted by Muta
Empower Clinics KAI Medical Laboratory Annual Revenue Run Rate Now Exceeding $10,000,000 USD. Empower Anticipates Order For Next 50,000 KAI Saliva PCR Test Kits To Prepare For Demand
AccessWire article from today
|
I am having a hard time finding any guidance in relation to their margin on these tests. Sure revenue is a nice story but their Q3 statements are dismal. In the 9 months YTD they burnt through $1.1M in cash from operations and their current ratio is alarming. They just had a significant warrant raise that only dilutes further. I personally have a hard time seeing a $200M valuation which is what it is trading at currently. A $10 or even $15M revenue run rate at best would suggest a 20x - 25x EBITDA to price, which is high.
Atleast that's how people used to look at stocks (fundamentals). It really is impossible to trade specs based on these.